Serum MicroRNAs as predictors for fibrosis progression and response to direct‐acting antivirals treatment in hepatitis C virus genotype‐4 Egyptian patients-Reference-Cited by-同舟云学术

Serum MicroRNAs as predictors for fibrosis progression and response to direct‐acting antivirals treatment in hepatitis C virus genotype‐4 Egyptian patients

Published:2020-12-28 Issue:4 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Khairy Rasha M. M.¹^ORCID,Hmmad Safaa Said¹,Sayed Mohamed¹,Ahmed Hazem A.¹,Esmail Mona Abdel Monem¹

Affiliation:

1. Department of Microbiology and Immunology Faculty of Medicine Minia University Minia Egypt

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.13954

Reference33 articles.

1. 2017 GHR.Geneva:World Health Organization.2017. licence: CCBY‐NC‐SA 3.0 IGO.

2. An overview about hepatitis C: A devastating virus

3. GAR‐WHO. n.d.WHO Hepatitis C.

4. Global epidemiology and genotype distribution of the hepatitis C virus infection

5. National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noninvasive Fibrosis Assessment in Chronic Hepatitis C Infection: An Update;Journal of Clinical and Translational Hepatology;2023-05-11

2. MiR-449a downregulation alleviates the progression of renal interstitial fibrosis by mediating the KLF4/MFN2 axis;International Urology and Nephrology;2023-02-12

3. Serum MicroRNAs as Predictors for HCV Progression and Response to Treatment in Pakistani Patients;Genes;2023-02-09

4. Exosome‐associated microRNA ‐375 induces cell proliferation by regulating IGFBP4 upon hepatitis C virus infection;Molecular Microbiology;2022-10-20

5. Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy;Genes & Diseases;2022-09